Perrigo (PRGO) Financials: Revenue & Earnings
PRGO$16.05+0.13 +0.82%
$2.22B
Market Cap
-1.27
P/E
7.33
Forward P/E
57
Score
Perrigo (PRGO) Financials: Revenue & Earnings
PRGO price $16.05 +0.13 +0.82%
- Ticker
- PRGO
- Price
- $16.05
- Change
- +0.13 +0.82%
- Market cap ?
- $2.22B
- P/E ?
- -1.27
- Forward P/E ?
- 7.33
- Dividend yield ?
- 7.33%
- Beta ?
- 0.54
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stocklytics score
- 57
- Value
- 72
- Quality
- 44
- Growth
- 55
Stocklytics score rationale: value 72, quality 44, growth 55.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 5280600000 | 4946200000 | 4731700000 | 3869900000 | 4088200000 | 4138700000 | 4451600000 | 4655600000 | 4373400000 | 4253100000 |
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte…
Earnings and financials
Perrigo Company plc (PRGO) trades at $16.05, with a market cap of $2.22B and a trailing P/E of -1.27. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 5280600000 | 4946200000 | 4731700000 | 3869900000 | 4088200000 | 4138700000 | 4451600000 | 4655600000 | 4373400000 | 4253100000 |
Insights · Dividends · Forecast · Financials · Learn